Welcome : Guest

INSULIN PUMPS (EXTERNAL) - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 15 companies including many key and niche players such as -

Debiotech S.A.
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic Plc.
Sooil Development Co. Ltd.
Tandem Diabetes Care Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-1511
Price: $4950
Companies: 15
Pages: 205
Date: October 2017
Market Data Tables: 63
  Status: * New Report



TABLE OF CONTENTS


  INSULIN PUMPS (EXTERNAL) (Complete Report) Pages : 205   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Insulin Pumps: A Prelude.....II-11$100
   Key Benefits Offered Infuse Sustained Growth Opportunities.....II-21$100
   Developed Regions Underpin Sales Growth.....II-3
The United States – The Largest Market.....II-3
Europe – A Market with Vast Potential.....II-3
1$100
   Lower Current Penetration Leaves Significant Room for Growth.....II-4
Table 1: Insulin Pumps Market by Region (2016): Percentage Breakdown of Number of Users for Established Markets and Rest of World (includes corresponding Graph/Chart).....II-4
1$350
   Table 2: Insulin Pump Penetration Rate (as a % of Total Diabetics) in Type 1 Diabetic Patients by Country (2016) (includes corresponding Graph/Chart).....II-5
Rising Incidence of Diabetes – A Major Market Driving Factor.....II-5
2$350
   Table 3: Global Diabetic Population by Region (2015 & 2040) (includes corresponding Graph/Chart).....II-71$350
   Table 4: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2015 (includes corresponding Graph/Chart).....II-8

Table 5: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2040 (includes corresponding Graph/Chart).....II-8
1$350
   Diabetes – Assessing the Economic Burden.....II-9
Table 6: Diabetes Related Healthcare Expenditure by Region: 2015 & 2040 (in US$ Billion) (includes corresponding Graph/Chart).....II-9
1$350
   Table 7: Major Spenders on Diabetes (2015): Annual Expenditure on Diabetes Treatment and Management in US$ Billion for Ten Leading Countries (includes corresponding Graph/Chart).....II-101$350
   Insulin Pumps Market – Set for Interesting Road Ahead.....II-11
Table 8: Leading Players in the Global External Insulin Pumps Market (2016): Percentage Breakdown of Value Sales for Insulet, J&J (Animas), Medtronic, Roche, Tandem and Others (includes corresponding Graph/Chart).....II-11
1$350
   Comparison of Select Durable Insulin Pumps by Manufacturer.....II-121$100
   Medtronic Banks on New Solutions and Distribution Expansion to Retain
  Dominance.....II-13
Tandem Sees Gradual Rise in Market Share.....II-13
Ypsomed Eyes Brighter Prospects with YpsoPump.....II-13
1$100
   Medtrum – A New Entrant with a Strong Product.....II-141$100
   Competitive Landscape in the Insulin Patch Pump Market.....II-15
Insulet’s OmniPod Benefits from Lack of Close Competition in its League.....II-15
Insulet Focuses on Advances in Technology and Services to Gain Market Share.....II-15
1$100
   Cellnovo’s Patch Pump Combines Functionality and Cost-Effectiveness.....II-161$100
   Valeritas’ V-Go – An Affordable Patch Pump for Type II Diabetics.....II-17
Valeritas Struggles to Push Sales of V-Go.....II-17
1$100
   Tough Ground for New Entrants.....II-181$100
   Type II Diabetes – A Market with Significant Potential.....II-19
Patch Pumps Gain Manufacturer Attention.....II-19
1$100
   Prefilled Insulin Cartridges Gain Popularity over Manual Filling.....II-20
The Rise of Smart Pumps – A Major Game Changer.....II-20
1$100
   Innovative Features Spruce Up the Market for Insulin Pumps.....II-21
Artificial Pancreas System (APS) – The Future of Diabetes Care.....II-21
1$100
   Artificial Pancreas – Are We There Yet?.....II-22
The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin
  Pumps.....II-22
1$100
   Table 9: Percentage Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart).....II-231$350
   Table 10: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart).....II-241$350
   Table 11: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart).....II-251$350
   Table 12: Life Expectancy for Select Countries in Number of Years: 2015 (includes corresponding Graph/Chart).....II-26
Alarming Rise in Obesity – A Business Case for Diabetes Care.....II-26
1$350
   Global Obesity Facts in a Nutshell.....II-27 1$100
   Table 13: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart).....II-28

Table 14: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart).....II-28
1$350
   Diabetes in Developing Countries to Expand Opportunities.....II-29
Table 15: Global External Insulin Pumps Market - Geographic Regions Ranked by % CAGR (Value Sales) for 2015-2022: Asia-Pacific, Latin America, US, Europe and Canada (includes corresponding Graph/Chart).....II-29
1$350
   ICR: A Key Factor to Success.....II-30
Customer Satisfaction: Crucial to Stay Competitive.....II-30
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.....II-30
Undiagnosed Diabetes – A Key Challenge.....II-30
1$100
   Better Safety Review – A Growing Need for Insulin Pumps.....II-31
Insulin Pump Training - Not Receiving Adequate Attention.....II-31
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.....II-31
1$100
   Competition from Other Insulin Delivery Technologies Continues.....II-32
Implantable Insulin Pumps – A Potential Threat to External Insulin Pumps.....II-32
1$100
   Lantus: A Threat to Insulin Pump Manufacturers.....II-331$100
   Diabetes - A Fatal Disease.....II-34
Risk Factors for Diabetes.....II-34
Types of Diabetes.....II-34
1$100
   Long Term Complications of Diabetes.....II-35
Testing Sugar Levels: Easy and Accurate.....II-35
Insulin.....II-35
Pancreas: The Main Source of Insulin in Human Body.....II-35
Types of Insulin.....II-35
1$100
   Types of Insulin & Onset of Action.....II-36
Goal of Insulin Therapy.....II-36
Insulin Delivery Systems.....II-36
1$100
   a. Syringes.....II-371$100
   b. Insulin Pens.....II-38
c. Jet Injectors.....II-38
d. Tablets.....II-38
e. External Insulin Pumps.....II-38
1$100
   f. Artificial Pancreas.....II-39
Insulin Delivery Technologies.....II-39
1$100
   Evolution of Insulin Pumps.....II-40
Components of Insulin Pump.....II-40
1$100
   How Does an Insulin Pump Work?.....II-41
Value-added Features of Modern Insulin Pumps.....II-41
Bolus Calculators.....II-41
Insulin on Board.....II-41
Customized Alarms.....II-41
Touch Bolus.....II-41
1$100
   Interface to PCs.....II-42
Others.....II-42
Insulin Pump Delivery Rates.....II-42
Guidelines for Insulin Pump Usage.....II-42
1$100
   Advantages.....II-43
More Accurate and Consistent.....II-43
Enhances Blood Sugar Control in Pediatric Patients.....II-43
Adjusting Time Zones While Traveling.....II-43
1$100
   Improves Quality of Life.....II-44
Patient Convenience.....II-44
Other Advantages.....II-44
Disadvantages/Risks Involved in the Usage of Insulin Pumps.....II-44
1$100
   High Cost.....II-45
High Involvement.....II-45
Diabetic Ketoacidosis Risk.....II-45
Glucose Testing at Regular Intervals.....II-45
Regular Rotation of Infusion Set.....II-45
Carrying Back-up Kit.....II-45
1$100
   Regular Refilling of Pump.....II-46
Other Disadvantages.....II-46
1$100
   Medtronic Rolls Out MiniMed™ 670G System.....II-47
Tandem Unveils New Software Update for t:slim® Insulin Pumps.....II-47
Tandem Introduces t:slim X2™ Insulin Pump with Dexcom G5® Mobile CGM
  Integration.....II-47
Tandem Launches t:lock™ Connector.....II-47
Tandem Receives US Patent for Infusion Pump and Electronic Device Integration.....II-47
SOOIL Development Unveils DANA Diabecare RS Insulin Pump.....II-47
1$100
   Cellnovo Files FDA 510(k) Clearance for Diabetes Management System.....II-48
Medtronic Obtains FDA Nod for its New MiniMed® 670G System.....II-48
Medtrum Launches Medtrum P6 Tubeless Insulin Pump.....II-48
Medtronic Launches MiniMed® 630G System.....II-48
Tandem Secures FDA Expanded Indication for t:slim® Insulin Pump.....II-48
EMA Clears Use of mylife™ YpsoPump® with NovoRapid® PumpCart®.....II-48
Animas Receives FDA Expanded Indication for Animas® Vibe® Insulin Pump in
  Children.....II-48
1$100
   Medtronic Introduces MiniMed Connect System for Insulin Pumps and CGMs.....II-49
Tandem Gets FDA Nod for t:slim G4 Insulin Pump.....II-49
Unilife Rolls Out Instant Patch Pumps Platform - Imperium™.....II-49
Medtronic Rolls Out MiniMed™ 640G System.....II-49
Tandem Bags FDA Clearance for t:flex Insulin Pump.....II-49
1$100
   Animas Decides to Exit Insulin Pump Business.....II-50
Tandem to Commence At-Home Pivotal Trial for t:slim X2™ Insulin Pump.....II-50
Aspire Capital Fund to Invest in Valeritas Holdings.....II-50
Roche Diabetes Care Discontinues Accu-Chek Brand in the US.....II-50
Insulet to Distribute its Omnipod System in Europe.....II-50
Valeritas Achieves Better Results with V-Go® Device.....II-50
1$100
   Valeritas Shows Quality Results with V-Go® Wearable Device.....II-51
Medtronic Collaborates with Aetna.....II-51
Roche to Acquire mySugr.....II-51
Tandem Announces Order Intake for t:slim X2™ Insulin Pump.....II-51
Bigfoot Secure FDA’s Clearance for Artificial Pancreas Trial.....II-51
Tandem Inks Technology Licensing Deal with TypeZero.....II-51
1$100
   Ypsomed and Novo Nordisk Sign Pact for mylife™ YpsoPump®.....II-52
UnitedHealth Group Selects Medtronic As Exclusive Supplier of Insulin Pumps.....II-52
Cellnovo and Roche Enter into Commercial Agreement for BGM.....II-52
Insulet Inks Deal with Mode for Licensing Artificial Pancreas Algorithm.....II-52
Ypsomed Expands Availability of mylife™ OmniPod® in Europe.....II-52
Medtronic Enters into Agreement with Chengdu Government to Produce Insulin
  Pumps.....II-52
Insulet and Eli Lilly Team Up to Develop New Version of OmniPod for Delivering Lilly's
  Humalog.....II-52
1$100
   Tandem and Dexcom Ink Deal to Pair their Devices.....II-53
BD Medical and Medtronic Collaborate to Launch New Infusion Set.....II-53
Bigfoot Biomedical Takes Over Asante Solutions.....II-53
Debiotech to Take Over Rights to iSense CGM.....II-53
Medtronic Acquires Covidien.....II-53
1$100
   Debiotech S.A. (Switzerland).....II-54
F. Hoffmann-La Roche, Ltd. (Switzerland).....II-54
1$100
   Insulet Corp. (USA).....II-55
Medtronic Plc. (Ireland).....II-55
1$100
   Sooil Development Co. Ltd. (Korea).....II-56
Tandem Diabetes Care Inc. (USA).....II-56
1$100
   Valeritas Inc. (USA).....II-57
Ypsomed Holding AG (Switzerland).....II-57
1$100
   Table 16: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-581$350
   Table 17: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-591$350
   Table 18: World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....II-601$350
   A. Market Analysis.....III-1
The Prime Market for Insulin Pumps.....III-1
Table 19: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s).....III-1
1$200
   Table 20: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart).....III-2

Table 21: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart).....III-2

Table 22: Diabetes Prevalence in the US (2015): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-2
1$200
   Table 23: US Market for Diabetes Management (2015 & 2018P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart).....III-3
Increasing Inclination towards Patch Pumps.....III-3
Artificial Pancreas System (APS): The Future of Diabetes Management.....III-3
1$200
   Select Clinical Studies on Artificial Pancreas Technology.....III-4
Competitive Scenario.....III-4
Comparison of Select Insulin Pump Systems Available in the US.....III-4
1$75
   Reimbursements.....III-5
Regulatory Scenario.....III-5
FDA Announces a New Mandate for Manufacturing Companies.....III-5
Product Approvals/Launches.....III-5
2$150
   Strategic Corporate Developments.....III-73$225
   Select Key Players.....III-102$150
   B. Market Analytics.....III-12
Table 24: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-12
1$200
   Table 25: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-131$200
   A. Market Analysis.....III-14
Current & Future Analysis.....III-14
Diabetes Statistics.....III-14
Table 26: Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart).....III-14
1$200
   Table 27: Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart).....III-151$200
   B. Market Analytics.....III-16
Table 28: Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-16
1$200
   Table 29: Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-171$200
   A. Market Analysis.....III-18
Current & Future Analysis.....III-18
Market Overview.....III-18
1$75
   Regional Scenario.....III-19
Diabetes Prevalence in Europe.....III-19
1$75
   Table 30: Diabetes Prevalence in Europe (2015): Prevalence of Type I & Type II Diabetes As Percentage of Adult Population (Aged 20 to 79 Years) by Country (includes corresponding Graph/Chart).....III-201$200
   Product Approval.....III-211$75
   B. Market Analytics.....III-22
Table 31: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-22
1$200
   Table 32: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-231$200
   Table 33: European 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Current & Future Analysis.....III-25
Strategic Corporate Development.....III-25
B. Market Analytics.....III-25
Table 34: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-25
1$200
   Table 35: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-261$200
   Market Analysis.....III-27
Table 36: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-27
1$200
   Table 37: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-281$200
   Market Analysis.....III-29
Table 38: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-29
1$200
   Table 39: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
Current & Future Analysis.....III-31
Enhanced Focus on Diabetes Management Drives Demand.....III-31
INPUT (The Insulin Pump Therapy Group).....III-31
1$75
   NICE (National Institute of Clinical Excellence).....III-32
Product Launch.....III-32
1$75
   B. Market Analytics.....III-33
Table 40: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-33
1$200
   Table 41: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-341$200
   Market Analysis.....III-35
Table 42: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-35
1$200
   Table 43: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-361$200
   Market Analysis.....III-37
Table 44: Russian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-37
1$200
   Table 45: Russian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Current & Future Analysis.....III-39
Product Launches.....III-39
Strategic Corporate Developments.....III-39
1$75
   Select Key Players.....III-403$225
   B. Market Analytics.....III-43
Table 46: Rest of Europe Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-43
1$200
   Table 47: Rest of Europe Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Asia-Pacific: A Rapidly Growing Market.....III-45
1$75
   Table 48: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart).....III-461$200
   Table 49: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-471$200
   Table 50: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart).....III-481$200
   Table 51: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-491$200
   Review of Select Markets.....III-50
China.....III-50
Overview.....III-50
China: An Untapped Goldmine.....III-50
India.....III-50
Diabetes Scenario.....III-50
1$75
   Insulin Pumps Market in India – An Overview.....III-51
New Indigenously Developed Product Could be the Answer.....III-51
Medtronic: The Current Market Leader.....III-51
1$75
   Diabetic Epidemic Spurs Indian Market.....III-52
Strategic Corporate Development.....III-52
1$75
   Key Player.....III-531$75
   B. Market Analytics.....III-54
Table 52: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-54
1$200
   Table 53: Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-551$200
   A. Market Analysis.....III-56
Current & Future Analysis.....III-56
Growing Population of Diabetics Spurs Demand.....III-56
1$75
   Table 54: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart).....III-571$200
   Table 55: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-581$200
   A Peek in to the Brazilian Insulin Pumps Market.....III-59
B. Market Analytics.....III-59
Table 56: Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-59
1$200
   Table 57: Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-601$200
   A. Market Analysis.....III-61
Current & Future Analysis.....III-61
Growing Prevalence of Diabetes: Key Market Driver.....III-61
Table 58: African Diabetes and Population Statistics (2015 & 2040P) (includes corresponding Graph/Chart).....III-61
1$200
   Table 59: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-621$200
   Table 60: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart).....III-631$200
   Table 61: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-641$200
   B. Market Analytics.....III-65
Table 62: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-65
1$200
   Table 63: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-661$200
  
Total Companies Profiled: 18 (including Divisions/Subsidiaries - 15)

Region/Country Players

The United States 11 Europe 6 France 1 The United Kingdom 1 Rest of Europe 4 Asia-Pacific (Excluding Japan) 1
Click here to request a full table of contents and more details on this project.